Preeclampsia is a complication that arises in five to eight percent of pregnancies. It causes high blood pressure (hypertension) and may also cause premature birth, organ dysfunction. It can also ...

MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin.

AI and metabolomics research links blood chemistry to aging, with aspartate emerging as a key biomarker of physical fitness and healthy longevity. (Nanowerk News) Could a simple blood test reveal how ...

A new study finds PTSD is linked to measurable changes in routine blood tests, revealing how trauma affects the body beyond ...

BOCA RATON, Fla., Jan. 22, 2026 /PRNewswire/ -- Doctors Studio by Forum Health, LLC today announced pilot findings indicating that intraprostatic ozone therapy was associated with measurable molecular ...

Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. Scientists have developed ...

A simple blood test which can detect traumatic head injuries can speed up diagnosis and reduce the need for detected by CT ...

Type 1 diabetes is an autoimmune disorder in which the immune system erroneously attacks cells in the pancreas that generate the hormone insulin. Since insulin regulates blood sugar levels, it is ...

Development could ‘dramatically’ reduce reliance on CT scans, speed up treatment and improve patient flow through emergency ...

Molecular diagnostics are specialized tests doctors use to look at proteins, RNA, and DNA in and on cancer cells. When you have breast cancer, they show your doctors what’s unique about your tumor so ...

A new blood test could diagnose pancreatic cancer much earlier, improving survival rates for people with the disease. A large part of the reason for this poor prognosis is that pancreatic cancer is ...

Data published in Journal of Clinical Oncology supports routine use of circulating tumor DNA (ctDNA) testing in management of stage III colon cancer patients Guardant Health, Inc. (Nasdaq: GH), a ...